Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devron H Char

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Ophthalmology Science|April 17, 2025
Novel Risk Factors for Uveal Melanoma in Adolescent and Young Adult Patients: A Comprehensive Case-Control AnalysisArina Nisanova, Susanna S Park, Aana Amin, et al.
International Journal of Radiation Oncology, Biology, Physics|April 6, 2015
Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body MelanomaKavita K Mishra, Jeanne M Quivey, Inder K Daftari, et al.
International Journal of Radiation Oncology, Biology, Physics|November 14, 2016
Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal MelanomaAlexei L Polishchuk, Kavita K Mishra, Vivian Weinberg, et al.
Melanoma Research|February 21, 2012
Expression of neurotrophin receptors by retinoinvasive uveal melanomaTatyana Milman, Dan-Ning Hu, Steven A McCormick, et al.
Ocular Oncology and Pathology|May 31, 2016
Investigation of Somatic GNAQ, GNA11, BAP1 and SF3B1 Mutations in Ophthalmic MelanocytomasJasmine H Francis, Thomas Wiesner, Tatyana Milman, et al.
Ophthalmology|July 14, 2022
Iris and Ciliary Body Melanocytomas Are Defined by Solitary GNAQ Mutation Without Additional Oncogenic AlterationsDavid A Solomon, Biswarathan Ramani, Maya Eiger-Moscovich, et al.
Cancers|June 26, 2025
Long-Term Clinical Outcomes for Adolescent and Young-Adult Uveal Melanoma Patients Treated with Dedicated Particle-Beam RadiationCarly Zako, Arina Nisanova, Vivian Weinberg, et al.
Biomedical Microdevices|February 6, 2015
Detection of GNAQ mutations and reduction of cell viability in uveal melanoma cells with functionalized gold nanoparticlesChristian Posch, Alfonso Latorre, Michelle B Crosby, et al.
Advances in Radiation Oncology|April 28, 2020
Practice Considerations for Proton Beam Radiation Therapy of Uveal Melanoma During the Coronavirus Disease Pandemic: Particle Therapy Co-Operative Group Ocular ExperienceKavita K Mishra, Armin Afshar, Juliette Thariat, et al.
The Open Ophthalmology Journal|March 15, 2011
Histopathologic findings of eyes enucleated after treatment with chemosurgery for retinoblastomaCarolyn P Graeber, Y Pierre Gobin, Brian P Marr, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Ophthalmology Science|April 17, 2025
Novel Risk Factors for Uveal Melanoma in Adolescent and Young Adult Patients: A Comprehensive Case-Control AnalysisArina Nisanova, Susanna S Park, Aana Amin, et al.
International Journal of Radiation Oncology, Biology, Physics|April 6, 2015
Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body MelanomaKavita K Mishra, Jeanne M Quivey, Inder K Daftari, et al.
International Journal of Radiation Oncology, Biology, Physics|November 14, 2016
Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal MelanomaAlexei L Polishchuk, Kavita K Mishra, Vivian Weinberg, et al.
Melanoma Research|February 21, 2012
Expression of neurotrophin receptors by retinoinvasive uveal melanomaTatyana Milman, Dan-Ning Hu, Steven A McCormick, et al.
Ocular Oncology and Pathology|May 31, 2016
Investigation of Somatic GNAQ, GNA11, BAP1 and SF3B1 Mutations in Ophthalmic MelanocytomasJasmine H Francis, Thomas Wiesner, Tatyana Milman, et al.
Ophthalmology|July 14, 2022
Iris and Ciliary Body Melanocytomas Are Defined by Solitary GNAQ Mutation Without Additional Oncogenic AlterationsDavid A Solomon, Biswarathan Ramani, Maya Eiger-Moscovich, et al.
Cancers|June 26, 2025
Long-Term Clinical Outcomes for Adolescent and Young-Adult Uveal Melanoma Patients Treated with Dedicated Particle-Beam RadiationCarly Zako, Arina Nisanova, Vivian Weinberg, et al.
Biomedical Microdevices|February 6, 2015
Detection of GNAQ mutations and reduction of cell viability in uveal melanoma cells with functionalized gold nanoparticlesChristian Posch, Alfonso Latorre, Michelle B Crosby, et al.
Advances in Radiation Oncology|April 28, 2020
Practice Considerations for Proton Beam Radiation Therapy of Uveal Melanoma During the Coronavirus Disease Pandemic: Particle Therapy Co-Operative Group Ocular ExperienceKavita K Mishra, Armin Afshar, Juliette Thariat, et al.
The Open Ophthalmology Journal|March 15, 2011
Histopathologic findings of eyes enucleated after treatment with chemosurgery for retinoblastomaCarolyn P Graeber, Y Pierre Gobin, Brian P Marr, et al.
Pageof 6